Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms

Summary

There is an urgent need for effective therapies against the novel COVID-19 virus. Studies have shown that amiodarone and verapamil can interfere with coronavirus entry and amplification by blocking ion channels. ReCOVery-SIRIO is a randomized study to investigate amiodarone or verapamil compared with usual care in symptomatic patients hospitalized with confirmed COVID-19 infection.

Timeline

Start

2020-05-20

Primary completion

2021-05-25

Completion

2021-06-05

Drugs

Indications